Skip to main content

Andrew Hindman

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Hindman

Andrew Hindman has spoken on 11 earnings calls across 1 company, most recently on November 7, 2022.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Organization not stated

    CFO

    Proxy statement

    Start not stated–2022-03-25

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

CFO

11 appearances Latest appearance 2022-11-07

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2022 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2022 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2022 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2021 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2021 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2021 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2021 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2020 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2020 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2020 Earnings Call

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2020 Earnings Call